Results 51 to 60 of about 48,951 (258)

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

open access: yesParasites & Vectors, 2015
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose.
Feli M. Walther   +2 more
doaj   +1 more source

Identification of the metabolites of ivermectin in humans

open access: yesPharmacology Research & Perspectives, 2021
Mass drug administration of ivermectin has been proposed as a possible malaria elimination tool. Ivermectin exhibits a mosquito‐lethal effect well beyond its biological half‐life, suggesting the presence of active slowly eliminated metabolites.
Phornpimon Tipthara   +9 more
doaj   +1 more source

Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia [PDF]

open access: yes, 2016
BACKGROUND: Strongyloides stercoralis is the only soil-transmitted helminth with the ability to replicate within its host, leading to long-lasting and potentially fatal infections. It is ubiquitous and its worldwide prevalence has recently been estimated
Virak Khieu (236174)   +23 more
core   +1 more source

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review

open access: yesJournal of antibiotics (Tokyo. 1968), 2021
Considering the urgency of the ongoing COVID-19 pandemic, detection of new mutant strains and potential re-emergence of novel coronaviruses, repurposing of drugs such as ivermectin could be worthy of attention.
A. Zaidi, P. Dehgani-Mobaraki
semanticscholar   +1 more source

Effects of the veterinary pharmaceutical ivermectin in indoor aquatic microcosms [PDF]

open access: yes, 2010
The effects of the parasiticide ivermectin were assessed in plankton-dominated indoor microcosms. Ivermectin was applied once at concentrations of 30, 100, 300, 1000, 3000, and 10,000 ng/l.
Reichman, E.P.   +6 more
core   +1 more source

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

open access: yesJournal of Medical Virology, 2021
Researchers around the world are working at record speed to find the best ways to treat and prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of ivermectin for the treatment of hospitalized mild to moderate COVID‐19 ...
S. Abdel-salam   +15 more
semanticscholar   +1 more source

Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi

open access: yesMalaria Journal, 2017
Background Outdoor malaria transmission hinders malaria elimination efforts in the Amazon region and novel vector control tools are needed. Ivermectin mass drug administration (MDA) to humans kills wild Anopheles, targets outdoor-feeding vectors, and can
Kevin C. Kobylinski   +9 more
doaj   +1 more source

Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical Trial [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: The rate of secondary attacks of SARS-COV-2 is high among household close contacts. Social distancing, isolation and infection control measures are important for preventing exposure to infection, but insufficient.
Waheed M Shoumann   +7 more
doaj   +1 more source

Ivermectin: An Anthelmintic, an Insecticide, and Much More

open access: yesTrends in Parasitology, 2020
Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and recent studies that have sought to reposition ivermectin for the treatment of other infectious diseases.
Richard J. Martin   +2 more
semanticscholar   +1 more source

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

open access: yesFuture Virology, 2021
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent.
Abhigyan Choudhury   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy